Qure.ai utilizes deep learning and artificial intelligence to enhance the detection and management of tuberculosis, lung cancer, and stroke through advanced medical imaging analysis. By providing rapid and accurate diagnostic support, Qure.ai improves treatment planning and patient outcomes across over 90 countries, impacting more than 25 million lives.
Funding
$156.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The increasing global burden of lung cancer, tuberculosis, and stroke necessitates faster and more accurate diagnostic tools to improve patient outcomes, particularly in resource-constrained settings with limited access to specialized radiologists. Traditional methods of medical image analysis can be time-consuming and prone to human error, leading to delays in diagnosis and treatment.
Solution
Qure.ai provides artificial intelligence-powered solutions that analyze medical images, including X-rays and CT scans, to enhance the detection and management of critical conditions such as lung cancer, tuberculosis, and stroke. The company's algorithms are designed to assist radiologists and clinicians in making quicker, more informed decisions by rapidly identifying abnormalities and prioritizing cases. Qure.ai's technology aims to improve diagnostic accuracy, reduce time to treatment, and facilitate scalable screening programs, ultimately improving patient care pathways and outcomes. The platform is designed to be machine-agnostic, working with both digital and analog X-ray systems, making it suitable for deployment in diverse healthcare environments.
Target Audience
The primary target audience includes radiologists, pulmonologists, neurologists, healthcare providers in hospitals and diagnostic centers, public health organizations, and government health ministries seeking to improve diagnostic accuracy and efficiency in medical imaging.
Features
- AI-powered analysis of chest X-rays and CT scans for rapid detection of lung nodules, TB, and stroke indicators
- Algorithms trained on a large dataset of medical images to ensure high accuracy and sensitivity
- Automated quantification of lung abnormalities to monitor disease progression
- Integration with existing radiology workflows for seamless adoption
- Cloud-based platform for easy accessibility and scalability
- Solutions are GDPR and HIPAA compliant, ensuring data privacy and security
- Algorithms can detect sub-optimal scans and flag them if needed
- Ability to process images captured using handheld devices, making it relevant in remote deployment sites